These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2218224)

  • 1. [Prevention of HIV infection in the methadone program. A study of a drop-in clinic in Zurich].
    Huber-Stemich F; Haas H
    Schweiz Rundsch Med Prax; 1990 Sep; 79(36):1017-21. PubMed ID: 2218224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
    Hartel DM; Schoenbaum EE
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with client-reported HIV infection among clients entering methadone treatment.
    MacGowan RJ; Fichtner RR; Swanson N; Collier C; Kroliczak A; Cole G
    AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HIV prevention in HIV-positive drug addicts. A methadone-supported model].
    Oertle D; Edelmann R; Ostewalder J; Vernazza PL; Galeazzi RL
    Schweiz Med Wochenschr; 1993 Dec; 123(48):2284-92. PubMed ID: 8272803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Health status of methadone recipients before entering a methadone program].
    Tschan F; Tueller N
    Schweiz Med Wochenschr; 1992 Nov; 122(46):1758-69. PubMed ID: 1448681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experiences from two HIV prevention projects among drug abusers in Oslo. Is methadone maintenance treatment useful?].
    Skogstad M
    Tidsskr Nor Laegeforen; 1990 Jun; 110(15):1978-80. PubMed ID: 2363170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the time of retention and related influencing factors of patients receiving methadone maintenance treatment in Hunan province].
    Li XL; Tan HZ; Sun ZQ; Zhang H; Chen MS; Ou QY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):672-5. PubMed ID: 19957587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus seropositivity in intravenous drug users in Ohio.
    Seligman PJ; Campbell RJ; Keeler GP; Halpin TJ
    Ohio Med; 1989 Jan; 85(1):56-9. PubMed ID: 2927870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of drug addicts with methadone in medical practice-- problems of the treatment of heroin addicts with methadone in view of the HIV epidemic].
    Fuchs WJ
    Schweiz Rundsch Med Prax; 1988 Mar; 77(13):354-7. PubMed ID: 3375659
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of HIV testing and high-risk behaviors among clients in methadone maintenance treatment.
    Grella CE; Campos M; Anglin MD
    AIDS Educ Prev; 1998 Oct; 10(5):403-16. PubMed ID: 9799937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term, medically supervised, drug-free treatment and methadone maintenance treatment on drug users' emergency department use and hospitalization.
    Turner BJ; Laine C; Yang CP; Hauck WW
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S457-63. PubMed ID: 14648464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients.
    Novick DM; Joseph H; Croxson TS; Salsitz EA; Wang G; Richman BL; Poretsky L; Keefe JB; Whimbey E
    Arch Intern Med; 1990 Jan; 150(1):97-9. PubMed ID: 2297301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City.
    Marmor M; Des Jarlais DC; Cohen H; Friedman SR; Beatrice ST; Dubin N; el-Sadr W; Mildvan D; Yancovitz S; Mathur U
    AIDS; 1987 May; 1(1):39-44. PubMed ID: 3122788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of patients with long-term methadone substitution].
    Coste JM; Kummer JA; Kraemer M; Porchet PA
    Rev Med Suisse; 2008 Oct; 4(175):2225-8. PubMed ID: 19024578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HIV infection in intravenous drug dependent patients--Vienna 1988 results].
    Loimer N; Presslich O; Hollerer E; Pfersmann V; Pakesch G; Pfersmann D
    Wien Med Wochenschr; 1989 Jul; 139(14):334-6. PubMed ID: 2788964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.